School of Chemistry and Chemical Engineering, David Keir Building, Queens University Belfast, Stranmillis Road, Belfast BT95AG, UK.
J Mol Graph Model. 2011 Jun;29(7):956-64. doi: 10.1016/j.jmgm.2011.04.002. Epub 2011 Apr 9.
HIV-1 integrase (IN) has become an attractive target since drug resistance against HIV-1 reverse transcriptase (RT) and protease (PR) has appeared. Diketo acid (DKA) inhibitors are potent and selective inhibitors of HIV-1 IN: however the action mechanism is not well understood. Here, to study the inhibition mechanism of DKAs we performed 10 ns comparative molecular dynamics simulations on HIV-1 IN bound with three most representative DKA inhibitors: Shionogi inhibitor, S-1360 and two Merck inhibitors L-731,988 and L-708,906. Our simulations show that the acidic part of S-1360 formed salt bridge and cation-π interactions with Lys159. In addition, the catalytic Glu152 in S-1360 was pushed away from the active site to form an ion-pair interaction with Arg199. The Merck inhibitors can maintain either one or both of these ion-pair interaction features. The difference in potencies of the DKA inhibitors is thus attributed to the different binding modes at the catalytic site. Such structural information at atomic level, not only demonstrates the action modes of DKA inhibitors but also provides a novel starting point for structural-based design of HIV-1 IN inhibitors.
HIV-1 整合酶(IN)已成为一个有吸引力的靶标,因为 HIV-1 逆转录酶(RT)和蛋白酶(PR)的耐药性已经出现。二酮酸(DKA)抑制剂是 HIV-1 IN 的有效且选择性抑制剂:然而,其作用机制尚不清楚。在这里,为了研究 DKA 的抑制机制,我们对与三种最具代表性的 DKA 抑制剂结合的 HIV-1 IN 进行了 10 ns 比较分子动力学模拟:Shionogi 抑制剂、S-1360 和两种默克抑制剂 L-731,988 和 L-708,906。我们的模拟表明,S-1360 的酸性部分与 Lys159 形成盐桥和阳离子-π 相互作用。此外,S-1360 中的催化 Glu152 被推离活性部位,与 Arg199 形成离子对相互作用。默克抑制剂可以保持这两种离子对相互作用特征中的一种或两种。因此,DKA 抑制剂的效力差异归因于催化部位的不同结合模式。这种原子水平的结构信息不仅展示了 DKA 抑制剂的作用模式,而且为基于结构的 HIV-1 IN 抑制剂设计提供了一个新的起点。